 The results of this study suggest that post-COVID patients with cardiovascular multimorbidity, CVMM, are older and have a greater number of chronic non-cardiac diseases than those without cardiovascular morbidities. Additionally, the quality of cardiovascular pharmacotherapy in these patients was poor at the time of discharge from the hospital, with subsequent non-significant decline over the course of one year follow-up. Furthermore, the frequency of anti-coagulation therapy in atrial fibrillation, AF, decreased significantly from 89.1% at the time of discharge to 56.4% after 30 to 60 days, and then to 53.6% after 6 and 12 months of monitoring. Additionally, there were higher rates of all-cause mortality, hospitalization, and non-fatal myocardial infarction in patients with CVMM, but the frequency of acute respiratory viral infections, ARVI, slash influenza was significantly higher in patients without cardiovascular morbidities. Finally, the rate of recurrent. This article was authored by A. A. Smirnov, M. M. Lukyanov, S. U. Mardsovich, and others. We are article.tv, links in the description below.